The immunogenetics of Psoriasis: A comprehensive review

Lowes, 2014, Immunology of psoriasis, Annu. Rev. Immunol., 32, 227, 10.1146/annurev-immunol-032713-120225 Perera, 2012, Psoriasis, Annu. Rev. pathology, 7, 385, 10.1146/annurev-pathol-011811-132448 Davidovici, 2010, Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions, J. Investigative Dermatology, 130, 1785, 10.1038/jid.2010.103 Di Cesare, 2009, The IL-23/Th17 axis in the immunopathogenesis of psoriasis, J. Investigative Dermatology, 129, 1339, 10.1038/jid.2009.59 Colombo, 2013, Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches, The Scientific World J., 2013, 805705, 10.1155/2013/805705 Ellis, 2001, Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes, N. Engl. J. Med., 345, 248, 10.1056/NEJM200107263450403 Mueller, 1979, Cyclosporin A for psoriasis, N. Engl. J. Med., 301, 555, 10.1056/NEJM197909063011015 Gottlieb, 1995, Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis, Nat. Med., 1, 442, 10.1038/nm0595-442 Lowes, 2007, Pathogenesis and therapy of psoriasis, Nature, 445, 866, 10.1038/nature05663 Lowes, 2005, Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a), Proc. Natl. Acad. Sci. U. S. A., 102, 19057, 10.1073/pnas.0509736102 Zaba, 2009, Resident and “inflammatory” dendritic cells in human skin, J. Investigative Dermatology, 129, 302, 10.1038/jid.2008.225 Wuepper, 1990, Psoriasis vulgaris: a genetic approach, J. Investigative Dermatology, 95, 2S, 10.1111/1523-1747.ep12505638 Bowcock, 2005, The genetics of psoriasis and autoimmunity, Annu. Rev. genomics Hum. Genet., 6, 93, 10.1146/annurev.genom.6.080604.162324 Elder, 2006, PSORS1: linking genetics and immunology, J. Investigative Dermatology, 126, 1205, 10.1038/sj.jid.5700357 Gourraud, 2014, HLA diversity in the 1000 genomes dataset, PloS One, 9, e97282, 10.1371/journal.pone.0097282 Strange, 2010, A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1, Nat. Genet., 42, 985, 10.1038/ng.694 Sun, 2010, Association analyses identify six new psoriasis susceptibility loci in the Chinese population, Nat. Genet., 42, 1005, 10.1038/ng.690 Yin, 2015, Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility, Nat. Commun., 6, 6916, 10.1038/ncomms7916 Okada, 2014, Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes, Am. J. Hum. Genet., 95, 162, 10.1016/j.ajhg.2014.07.002 Gonzalez, 2008, NKG2D ligands: key targets of the immune response, Trends Immunol., 29, 397, 10.1016/j.it.2008.04.007 Lew, 2004, Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and “Type 1” inflammatory gene expression, Trends Immunol., 25, 295, 10.1016/j.it.2004.03.006 Harden, 2015, Humanized anti-IFN-gamma (HuZAF) in the treatment of psoriasis, J. allergy Clin. Immunol., 135, 553, 10.1016/j.jaci.2014.05.046 McGeachy, 2009, The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo, Nat. Immunol., 10, 314, 10.1038/ni.1698 Kagami, 2010, Circulating Th17, Th22, and Th1 cells are increased in psoriasis, J. Investigative Dermatology, 130, 1373, 10.1038/jid.2009.399 Oppmann, 2000, Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12, Immunity, 13, 715, 10.1016/S1074-7613(00)00070-4 Nair, 2008, Polymorphisms of the IL12B and IL23R genes are associated with psoriasis, J. Investigative Dermatology, 128, 1653, 10.1038/sj.jid.5701255 Nair, 2009, Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways, Nat. Genet., 41, 199, 10.1038/ng.311 Cargill, 2007, A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes, Am. J. Hum. Genet., 80, 273, 10.1086/511051 Di Meglio, 2011, The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans, PloS One, 6, e17160, 10.1371/journal.pone.0017160 Zou, 1997, Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases, J. Biol. Chem., 272, 6073, 10.1074/jbc.272.9.6073 Parham, 2002, A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R, J. Immunol., 168, 5699, 10.4049/jimmunol.168.11.5699 Ellinghaus, 2012, Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci, Am. J. Hum. Genet., 90, 636, 10.1016/j.ajhg.2012.02.020 Tsoi, 2012, Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity, Nat. Genet., 44, 1341, 10.1038/ng.2467 Sofen, 2014, Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis, J. allergy Clin. Immunol., 133, 1032, 10.1016/j.jaci.2014.01.025 Kopp, 2015, Clinical improvement in psoriasis with specific targeting of interleukin-23, Nature, 521, 222, 10.1038/nature14175 Papp, 2015, Tildrakizumab (MK-3222), an Anti- IL-23p19 Monoclonal Antibody, Improves Psoriasis in a Phase 2b Randomized Placebo- Controlled Trial, Br. J. Dermatology, 10.1111/bjd.13932 Chiricozzi, 2013, IL-17 targeted therapies for psoriasis, Expert Opin. Investigational Drugs, 22, 993, 10.1517/13543784.2013.806483 Djuretic, 2007, Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells, Nat. Immunol., 8, 145, 10.1038/ni1424 Wong, 2011, Interplay of transcription factors in T-cell differentiation and function: the role of Runx, Immunology, 132, 157, 10.1111/j.1365-2567.2010.03381.x Faridi, 2013, Aberrant epigenetic regulators control expansion of human CD34+ hematopoietic stem/progenitor cells, Front. Genet., 4, 254, 10.3389/fgene.2013.00254 Ono, 2007, Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1, Nature, 446, 685, 10.1038/nature05673 Bruno, 2009, Runx proteins regulate Foxp3 expression, J. Exp. Med., 206, 2329, 10.1084/jem.20090226 Kitoh, 2009, Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells, Immunity, 31, 609, 10.1016/j.immuni.2009.09.003 Helms, 2003, A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis, Nat. Genet., 35, 349, 10.1038/ng1268 Andres, 2013, Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity, Exp. Dermatol., 22, 323, 10.1111/exd.12128 Harris, 2007, Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity, J. Immunol., 179, 4313, 10.4049/jimmunol.179.7.4313 Tarutani, 2013, Epidermal hyperplasia induced by Raf-MAPK signaling requires Stat3 activation, J. Dermatological Sci., 72, 110, 10.1016/j.jdermsci.2013.06.007 Mao, 2004, T lymphocyte activation gene identification by coregulated expression on DNA microarrays, Genomics, 83, 989, 10.1016/j.ygeno.2003.12.019 Hunt, 2008, Newly identified genetic risk variants for celiac disease related to the immune response, Nat. Genet., 40, 395, 10.1038/ng.102 Raychaudhuri, 2009, Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk, Nat. Genet., 41, 1313, 10.1038/ng.479 Festen, 2011, A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease, PLoS Genet., 7, e1001283, 10.1371/journal.pgen.1001283 Patsopoulos, 2011, Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci, Ann. Neurology, 70, 897, 10.1002/ana.22609 Chang, 2008, Variants in the 5q31 cytokine gene cluster are associated with psoriasis, Genes Immun., 9, 176, 10.1038/sj.gene.6364451 Muranski, 2013, Essentials of Th17 cell commitment and plasticity, Blood, 121, 2402, 10.1182/blood-2012-09-378653 Hirahara, 2011, Helper T-cell differentiation and plasticity: insights from epigenetics, Immunology, 134, 235, 10.1111/j.1365-2567.2011.03483.x Li, 2012, Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases, J. Allergy Clin. Immunol., 130, 861, 10.1016/j.jaci.2012.04.041 Goldminz, 2013, NF-kappaB: an essential transcription factor in psoriasis, J. Dermatological Sci., 69, 89, 10.1016/j.jdermsci.2012.11.002 Hoesel, 2013, The complexity of NF-kappaB signaling in inflammation and cancer, Mol. Cancer, 12, 86, 10.1186/1476-4598-12-86 Perkins, 2007, Integrating cell-signalling pathways with NF-kappaB and IKK function, Nat. Rev. Mol. Cell Biol., 8, 49, 10.1038/nrm2083 Lizzul, 2005, Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept, J. Investigative Dermatology, 124, 1275, 10.1111/j.0022-202X.2005.23735.x Stuart, 2010, Genome-wide association analysis identifies three psoriasis susceptibility loci, Nat. Genet., 42, 1000, 10.1038/ng.693 Lorenz, 2014, c-Rel downregulation affects cell cycle progression of human keratinocytes, J. Investigative Dermatology, 134, 415, 10.1038/jid.2013.315 Huffmeier, 2010, Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis, Nat. Genet., 42, 996, 10.1038/ng.688 Ellinghaus, 2010, Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2, Nat. Genet., 42, 991, 10.1038/ng.689 Suzuki, 2014, The IL-23/IL-17 axis in psoriatic arthritis, Autoimmun. Rev., 13, 496, 10.1016/j.autrev.2014.01.050 Chang, 2011, Signaling of interleukin-17 family cytokines in immunity and inflammation, Cell. Signal., 23, 1069, 10.1016/j.cellsig.2010.11.022 Wu, 2015, Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6, J. Investigative Dermatology, 135, 490, 10.1038/jid.2014.383 Blonska, 2011, NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins, Cell Res., 21, 55, 10.1038/cr.2010.182 Jordan, 2012, PSORS2 is due to mutations in CARD14, Am. J. Hum. Genet., 90, 784, 10.1016/j.ajhg.2012.03.012 Jordan, 2012, Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis, Am. J. Hum. Genet., 90, 796, 10.1016/j.ajhg.2012.03.013 Scudiero, 2011, Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-kappaB activation and endoplasmic reticulum stress-induced cell death, J. Cell. physiology, 226, 3121, 10.1002/jcp.22667 Harden, 2014, CARD14 expression in dermal endothelial cells in Psoriasis, PloS One, 9, e111255, 10.1371/journal.pone.0111255 Vabret, 2013, Sensing microbial RNA in the cytosol, Front. Immunol., 4, 468, 10.3389/fimmu.2013.00468 Reikine, 2014, Pattern recognition and signaling mechanisms of RIG-I and MDA5, Front. Immunol., 5, 342, 10.3389/fimmu.2014.00342 Schmid, 1994, The type I interferon system is locally activated in psoriatic lesions, J. Interferon Res., 14, 229, 10.1089/jir.1994.14.229 Yao, 2008, Type I interferon: potential therapeutic target for psoriasis?, PloS One, 3, e2737, 10.1371/journal.pone.0002737 van der Fits, 2004, In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered, J. Investigative Dermatology, 122, 51, 10.1046/j.0022-202X.2003.22113.x Kitamura, 2007, Cytokine modulation of retinoic acid-inducible gene-I (RIG-I) expression in human epidermal keratinocytes, J. Dermatological Sci., 45, 127, 10.1016/j.jdermsci.2006.11.003 Racz, 2011, Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes, Br. J. Dermatology, 164, 838, 10.1111/j.1365-2133.2010.10169.x Prens, 2008, IFN-alpha enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors: relevance for psoriasis, J. Investigative Dermatology, 128, 932, 10.1038/sj.jid.5701087 Bijlmakers, 2011, Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis, Hum. Mol. Genet., 20, 3129, 10.1093/hmg/ddr215 Li, 2010, Carriers of rare missense variants in IFIH1 are protected from psoriasis, J. Investigative Dermatology, 130, 2768, 10.1038/jid.2010.214 Xue, 2015, SRSF1 facilitates cytosolic DNA-induced production of type I interferons recognized by RIG-I, PloS One, 10, e0115354, 10.1371/journal.pone.0115354 Ganguly, 2009, Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8, J. Exp. Med., 206, 1983, 10.1084/jem.20090480 Zuo, 2015, Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis, Nat. Commun., 6, 6793, 10.1038/ncomms7793 Ramirez, 2012, Emerging roles for TNIP1 in regulating post-receptor signaling, Cytokine & Growth Factor Rev., 23, 109, 10.1016/j.cytogfr.2012.04.002 Mauro, 2006, ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB, J. Biol. Chem., 281, 18482, 10.1074/jbc.M601502200 Zhang, 2009, Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21, Nat. Genet., 41, 205, 10.1038/ng.310 Stahl, 2010, Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci, Nat. Genet., 42, 508, 10.1038/ng.582 Han, 2009, Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus, Nat. Genet., 41, 1234, 10.1038/ng.472 Graham, 2008, Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus, Nat. Genet., 40, 1059, 10.1038/ng.200 Heyninck, 1999, The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN, J. cell Biol., 145, 1471, 10.1083/jcb.145.7.1471 Flores, 2011, TNIP1 is a corepressor of agonist-bound PPARs, Archives Biochem. biophysics, 516, 58, 10.1016/j.abb.2011.08.014 Roberson, 2012, A subset of methylated CpG sites differentiate psoriatic from normal skin, J. Investigative Dermatology, 132, 583, 10.1038/jid.2011.348 Hayden, 2008, Shared principles in NF-kappaB signaling, Cell, 132, 344, 10.1016/j.cell.2008.01.020 Liu, 2013, Zc3h12c inhibits vascular inflammation by repressing NF-kappaB activation and pro-inflammatory gene expression in endothelial cells, Biochem. J., 451, 55, 10.1042/BJ20130019 Liang, 2008, A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages, J. Biol. Chem., 283, 6337, 10.1074/jbc.M707861200 Marrakchi, 2011, Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis, N. Engl. J. Med., 365, 620, 10.1056/NEJMoa1013068 Onoufriadis, 2011, Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis, Am. J. Hum. Genet., 89, 432, 10.1016/j.ajhg.2011.07.022 Yoshimura, 2012, SOCS, Inflammation, and Autoimmunity, Front. Immunol., 3, 20, 10.3389/fimmu.2012.00020 Ilangumaran, 2003, Regulation of cytokine receptor signaling by SOCS1, Immunol. Rev., 192, 196, 10.1034/j.1600-065X.2003.00020.x Yoshimura, 2009, Regulation of cytokine signaling by the SOCS and Spred family proteins, Keio J. Med., 58, 73, 10.2302/kjm.58.73 Quaranta, 2014, Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema, Sci. Transl. Med., 6, 10.1126/scitranslmed.3008946 Coimbra, 2015, A specific molecular signature for psoriasis and eczema, Ann. Transl. Med., 3, 76 Uotila, 2001, Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer, Urological Res., 29, 23, 10.1007/s002400000148 Klotz, 1998, Selective expression of inducible nitric oxide synthase in human prostate carcinoma, Cancer, 82, 1897, 10.1002/(SICI)1097-0142(19980515)82:10<1897::AID-CNCR12>3.0.CO;2-O Glynn, 2010, Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients, J. Clin. Investigation, 120, 3843, 10.1172/JCI42059 Heinecke, 2014, Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression, Proc. Natl. Acad. Sci. U. S. A., 111, 6323, 10.1073/pnas.1401799111 Obermajer, 2013, Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling, J. Exp. Med., 210, 1433, 10.1084/jem.20121277 Donnelly, 2010, Interferon-lambda: a new addition to an old family. Journal of interferon & cytokine research, Official J. Int. Soc. Interferon Cytokine Res., 30, 555, 10.1089/jir.2010.0078 Doyle, 2006, Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes, Hepatology, 44, 896, 10.1002/hep.21312 Sommereyns, 2008, IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo, PLoS Pathog., 4, e1000017, 10.1371/journal.ppat.1000017 Lovendorf, 2015, Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis, Exp. Dermatol., 24, 187, 10.1111/exd.12604 Pivarcsi, 2014, Genetic polymorphisms altering microRNA activity in psoriasis–a key to solve the puzzle of missing heritability?, Exp. Dermatol., 23, 620, 10.1111/exd.12469 Zhang, 2014, A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study, J. Cell. Mol. Med., 18, 2225, 10.1111/jcmm.12359 Nanney, 1986, Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis, J. Investigative Dermatology, 86, 260, 10.1111/1523-1747.ep12285389 Bowes, 2015, Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis, Nat. Commun., 6, 6046, 10.1038/ncomms7046 Prieto-Perez, 2013, Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases, Pharmacogenomics J., 13, 297, 10.1038/tpj.2012.53 Tejasvi, 2012, TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis, J. Investigative Dermatology, 132, 593, 10.1038/jid.2011.376